Steve Jennings has been named senior vice president of sales, marketing and business development, AMRI. Mr. Jennings will be responsible for all of AMRI’s global sales efforts, including sales teams in the U.S., Asia and Europe.

He has more than 30 years of leadership and global sales experience, with a background in business development and licensing in both the pharmaceutical and medical device sectors. He spent 10 years at Solvay Pharmaceuticals in domestic and international sales management roles. He rose from regional sales director to vice president of global marketing for the Gastroenterology and Women’s Health business units. He led a 450-person sales force and managed the launch of several products, including one with annual revenue of $200 million.

Prior to Solvay, Mr. Jennings held sales leadership roles with both Ciba Geigy (currently Novartis) and Reed and Carnick Pharmaceuticals. Most recently, he was vice president of sales at Cyberonics, Inc., a medical device company specializing in neurological and psychiatric illness.

“We are pleased to announce the addition of Steve Jennings to AMRI’s senior leadership team,” said AMRI chairman, president and chief executive officer Thomas E. D’Ambra. “Steve has an exceptional track record in sales and marketing in the pharmaceutical and medical device industry. We expect him to play a key leadership role in the continued growth of our sales force to support our expanding operations and technologies around the globe. His prior experience in building, training and directing differentiated sales teams will be a key skill as we continue to rapidly expand AMRI’s sales presence around the world. His depth of knowledge in the due diligence process of potential product and company acquisitions will bring additional expertise to AMRI’s leadership team in its strategic planning process.”